PACS developer Cemax is puttingthe regulatory pieces together for its line of image managementand archiving products. Cemax received Food and Drug Administration510(k) marketing clearance last month for its ClinicalView andDiagnosticView workstations,
PACS developer Cemax is puttingthe regulatory pieces together for its line of image managementand archiving products. Cemax received Food and Drug Administration510(k) marketing clearance last month for its ClinicalView andDiagnosticView workstations, two of the products in the Fremont,CA, vendor's Perfect Vision series of display technology.
ClinicalView is a Sun-based display station designed for nurses,physicians and technologists at hospital locations outside theradiology department, such as emergency and critical care units.The workstation has a resolution of 1280 x 1600 on a 24-inch portraitmonitor.
DiagnosticView, also a Sun-based system, is a review stationwith 2000 x 2000-pixel resolution, 21-inch portrait monitors foruse by radiologists. Both workstations support Fuji and Du Pontcomputed radiography devices and interfaces with Lumisys and DuPont digitizers.
The display stations archive to 8-mm digital tape and aresupported by the company's ImageServer distributed image managementand archiving architecture. Cemax received FDA clearance for itsImageServer software last year (SCAN 12/29/93).
Cemax signed a joint sales and marketing agreement with 3Min February for the Perfect Vision products. 3M unveiled the Cemaxline as the 3M Image Management System at last month's AmericanInstitute of Ultrasound in Medicine meeting.
Can Abbreviated MRI Have an Impact in Rectal Cancer Staging?
April 4th 2025Abbreviated MRI demonstrated a 95.3 percent specificity for rectal cancer and provided strong agreement with the full MRI protocol for T staging and detection of extramural venous invasion, according to newly published research.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.